,2,3,4 TSAs presented at the cell surface by major histocompatibility complex (MHC) (human leukocyte antigen [HLA] in human) class I or class II molecules are unique to an individual’s tumor and are not found in healthy cells, making them ideal targets for cancer vaccines and immune-based therapies. Here, HLA-C is linked to cancer.